{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:46:42Z","timestamp":1780670802997,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1053\/bega.2002.0341","type":"journal-article","created":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T01:48:30Z","timestamp":1039571310000},"page":"957-970","source":"Crossref","is-referenced-by-count":4,"title":["Expected developments in hepatology"],"prefix":"10.1053","volume":"16","author":[{"given":"Xavier","family":"Forns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"S\u00e1nchez Tapias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Par\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Llovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bruix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Rod\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2002.0341_RF1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/he.2000.6709","article-title":"Clinical relevance of hepatitis B viral mutations","volume":"31","author":"Hunt","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u2018occult\u2019?","volume":"34","author":"Brechot","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/jhep.2000.19789","article-title":"Hepatitis B immune globulin to prevent hepatitis B graft reinfection after liver transplantation","volume":"32","author":"Shouval","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF5","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/gast.2001.24839","article-title":"Management of hepatitis B: 2000 \u2013 summary of a workshop","volume":"120","author":"Lok","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0341_RF6","first-page":"693","article-title":"The molecular biology of hepatitis C virus","volume":"3","author":"Forns","year":"1999","journal-title":"Genotypes and Quasispecies"},{"key":"10.1053\/bega.2002.0341_RF7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-8278(01)00088-5","article-title":"Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center","volume":"35","author":"Forns","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a new target for the treatment of liver fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2002.0341_RF9","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2002.0341_RF10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. A randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/bega.2002.0341_RF11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2001.1316","article-title":"Advances in model systems for hepatitis C virus research","volume":"293","author":"Landford","year":"2002","journal-title":"Virology"},{"key":"10.1053\/bega.2002.0341_RF12","first-page":"469A","article-title":"Expression of pyruvate dehydrogenase complex PDC-E2 on biliary epithelial cells induced by incubation with lymph nodes from primary biliary cirrhosis","volume":"4","author":"Keogh","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/bega.2002.0341_RF14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/gut.47.4.586","article-title":"PBC: an infectious disease?","volume":"47","author":"Haydon","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0341_RF15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(94)80117-7","article-title":"Cross reactivity of anti- Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis","volume":"21","author":"Vilagut","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2362.1997.1690724.x","article-title":"Antibodies to mycobacterial 65-kD heat shock protein cross-react with the main mitochondrial antigens in patients with primary biliary cirrosis","volume":"27","author":"Vilagut","year":"1997","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1053\/bega.2002.0341_RF17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0168-8278(98)80317-6","article-title":"Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis","volume":"28","author":"O'Donohue","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF18","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0168-8278(05)80986-9","article-title":"Mycobacterium gordonae DNA in liver tissue of patients with primary biliary cirrhosis","volume":"21","author":"Vilagut","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1034\/j.1600-0641.2000.033004528.x","article-title":"Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis","volume":"33","author":"Mayo","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(01)00252-5","article-title":"Antibodies against homologous microbial caseinolytic proteases P characterize primary biliary cirrosis","volume":"36","author":"Bogdanos","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF21","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1053\/jhep.2001.22653","article-title":"Molecular identification of bacterial 16S ribosomal RNA in liver tissue of primary biliary cirrosis. IsPropionibacterium acnes involved in granuloma formation?","volume":"33","author":"Harada","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF22","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0140-6736(97)10290-2","article-title":"Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders","volume":"351","author":"Mason","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/bega.2002.0341_RF23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1572-0241.2001.03446.x","article-title":"Genetic and familiar considerations in primary biliary cirrhosis","volume":"96","author":"Tanaka","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2002.0341_RF24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(89)90643-4","article-title":"Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis: clinical and histological follow up studies","volume":"97","author":"Polson","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0341_RF25","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.167.5.2956","article-title":"Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis","volume":"167","author":"Long","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1053\/bega.2002.0341_RF26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in PSC: a study of explanted livers","volume":"28","author":"Olsson","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF27","series-title":"Primary Sclerosing Cholangitis","first-page":"37","article-title":"Aetiopathogenesis of primary sclerosing cholangitis","author":"Vierling","year":"1998"},{"key":"10.1053\/bega.2002.0341_RF28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1053\/bega.2002.0341_RF29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the TNF\u03b1-308 but not the interleukin-10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1053\/bega.2002.0341_RF30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: GLOBOCAN 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"International Journal of Cancer"},{"key":"10.1053\/bega.2002.0341_RF32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference","volume":"35","author":"Bruix","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2002.0341_RF33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/scbi.2000.0319","article-title":"Genetics of hepatocellular carcinoma","volume":"10","author":"Buendia","year":"2000","journal-title":"Seminars in Cancer Biology"},{"key":"10.1053\/bega.2002.0341_RF35","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection vs transplantation","volume":"39","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2002.0341_RF36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2007-1007118","article-title":"Histopathologic evaluation of hepatocelluar carcinoma with special reference to small early tumors","volume":"19","author":"Kojiro","year":"1999","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2002.0341_RF37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0016-5085(95)90402-6","article-title":"Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients","volume":"109","author":"Castells","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2002.0341_RF38","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","volume":"332","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2002.0341_RF39","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolization, chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/bega.2002.0341_RF40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ni0402-318","article-title":"Therapeutic applications for hematopoietic stem cell gene transfer","volume":"3","author":"Bordignon","year":"2002","journal-title":"Nature Immunology"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691802903410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691802903410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T04:55:44Z","timestamp":1554180944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691802903410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S1521691802903410"],"URL":"https:\/\/doi.org\/10.1053\/bega.2002.0341","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}